US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist

4.1200
-0.2800-6.36%

Close Nov 27 16:00 ET

4.2000
+0.0800+1.94%

Post 20:01 ET

278.46MMarket Cap-2765P/E (TTM)

Perspective Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

133.29%3.37M

-10.28%-8.9M

242.43%13.85M

-506.52%-36.91M

-211.59%-9.01M

-610.97%-10.11M

-8.07M

-9.72M

-114.52%-6.09M

-158.59%-2.89M

Net income from continuing operations

-46.02%-15.12M

-5.38%-11.7M

-3,211.05%-12.28M

-534.06%-46.51M

-1,087.44%-24.68M

-668.82%-10.36M

---11.11M

---371K

-116.56%-7.34M

-95.85%-2.08M

Operating gains losses

225.00%39K

--63K

-90.91%2K

-87.21%39K

--5K

--12K

--0

--22K

2,950.00%305K

----

Depreciation and amortization

158.30%669K

132.65%570K

92.22%346K

585.51%946K

303.08%262K

304.69%259K

--245K

--180K

-7.38%138K

54.76%65K

Deferred tax

--0

---2.65M

--7.85M

--0

---10.5M

----

Other non cash items

-850.00%-510K

25.00%-9K

-1,440.00%-268K

2,414.52%4.31M

19,122.73%4.23M

277.78%68K

---12K

--20K

-358.33%-186K

4.76%22K

Change In working capital

3,105.88%16.35M

15.26%1.5M

5,845.70%25.4M

617.50%2.3M

287.67%1.98M

-73.25%-544K

--1.3M

---442K

577.61%320K

-328.46%-1.05M

-Change in receivables

78.48%-133K

241.43%857K

16,700.00%166K

-273.88%-426K

-110.90%-58K

-25.35%-618K

--251K

---1K

690.32%245K

8,766.67%532K

-Change in inventory

--0

-200.00%-16K

-78.91%27K

572.37%359K

105.09%102K

34.52%113K

--16K

--128K

72.26%-76K

-1,406.77%-2M

-Change in prepaid assets

-293.00%-882K

115.84%61K

-156.67%-154K

-30.52%-325K

-400.89%-337K

3,908.33%457K

---385K

---60K

-344.64%-249K

11,100.00%112K

-Change in payables and accrued expense

3,601.41%17.37M

-57.74%601K

-419.25%-2.64M

572.00%2.69M

642.16%2.27M

-563.55%-496K

--1.42M

---509K

72.41%400K

355.00%306K

-Change in other working capital

--0

--28M

----

Cash from discontinued investing activities

Operating cash flow

133.29%3.37M

-10.28%-8.9M

242.43%13.85M

-506.52%-36.91M

-211.59%-9.01M

-610.97%-10.11M

---8.07M

---9.72M

-114.52%-6.09M

-158.59%-2.89M

Investing cash flow

Cash flow from continuing investing activities

-13,000.00%-29.74M

-475.04%-3.3M

-287.23%-47.3M

184.51%24.37M

27.64%-89K

-773.08%-227K

-573K

25.26M

-6,933.90%-28.84M

10.87%-123K

Net PPE purchase and sale

-12,989.43%-29.71M

-82.88%-1.02M

-4,413.43%-9.07M

-609.93%-1.07M

15.24%-89K

-773.08%-227K

---555K

---201K

60.26%-151K

8.70%-105K

Net business purchase and sale

--0

--2.7M

--0

--2.7M

----

Net investment purchase and sale

--0

---2.28M

-267.92%-38.23M

200.33%22.76M

--0

--22.76M

---22.69M

----

Net other investing changes

----

99.70%-18K

--0

----

-19,900.00%-6M

----

Cash from discontinued investing activities

Investing cash flow

-13,000.00%-29.74M

-475.04%-3.3M

-287.23%-47.3M

184.51%24.37M

27.64%-89K

-773.08%-227K

---573K

--25.26M

-6,933.90%-28.84M

10.87%-123K

Financing cash flow

Cash flow from continuing financing activities

62,700.00%628K

23,744.53%122.08M

208,010.00%166.33M

2,703.57%785K

352K

512K

-80K

-99.96%28K

Net issuance payments of debt

23.81%-16K

60.00%-8K

20.00%-12K

---68K

---12K

---21K

---20K

---15K

----

Net common stock issuance

---123K

--235.04M

--53.14M

--364K

--0

Cash dividends paid

----

--0

Proceeds from stock option exercised by employees

3,386.36%767K

-1,994.74%-10.08M

--10.33M

1,878.57%554K

--0

--22K

--532K

--0

-94.76%28K

--0

Net other financing activities

----

158,353.85%102.87M

---65K

--0

---65K

----

Cash from discontinued financing activities

Financing cash flow

62,700.00%628K

23,744.53%122.08M

208,010.00%166.33M

2,703.57%785K

--352K

--1K

--512K

---80K

-99.96%28K

--0

Net cash flow

Beginning cash position

784.83%252.19M

288.43%142.3M

-55.51%9.42M

-62.24%21.18M

-69.26%18.17M

-52.92%28.5M

--36.63M

--21.18M

2,079.25%56.07M

-9.13%59.09M

Current changes in cash

-149.06%-25.74M

1,451.13%109.89M

759.56%132.88M

66.32%-11.76M

-190.15%-8.75M

-613.81%-10.34M

---8.13M

--15.46M

-156.80%-34.9M

-197.53%-3.01M

End cash Position

1,146.59%226.44M

784.83%252.19M

288.43%142.3M

-55.51%9.42M

-83.20%9.42M

-69.26%18.17M

--28.5M

--36.63M

-66.92%21.18M

-12.40%56.07M

Free cash flow

-154.88%-26.35M

-14.95%-9.92M

148.13%4.78M

-509.03%-37.99M

-203.64%-9.1M

-613.88%-10.34M

---8.63M

---9.92M

-93.82%-6.24M

-142.98%-3M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	133.29%3.37M	-10.28%-8.9M	242.43%13.85M	-506.52%-36.91M	-211.59%-9.01M	-610.97%-10.11M	-8.07M	-9.72M	-114.52%-6.09M	-158.59%-2.89M
Net income from continuing operations	-46.02%-15.12M	-5.38%-11.7M	-3,211.05%-12.28M	-534.06%-46.51M	-1,087.44%-24.68M	-668.82%-10.36M	---11.11M	---371K	-116.56%-7.34M	-95.85%-2.08M
Operating gains losses	225.00%39K	--63K	-90.91%2K	-87.21%39K	--5K	--12K	--0	--22K	2,950.00%305K	----
Depreciation and amortization	158.30%669K	132.65%570K	92.22%346K	585.51%946K	303.08%262K	304.69%259K	--245K	--180K	-7.38%138K	54.76%65K
Deferred tax	--0	--0	--0	---2.65M	--7.85M	--0	--0	---10.5M	----	----
Other non cash items	-850.00%-510K	25.00%-9K	-1,440.00%-268K	2,414.52%4.31M	19,122.73%4.23M	277.78%68K	---12K	--20K	-358.33%-186K	4.76%22K
Change In working capital	3,105.88%16.35M	15.26%1.5M	5,845.70%25.4M	617.50%2.3M	287.67%1.98M	-73.25%-544K	--1.3M	---442K	577.61%320K	-328.46%-1.05M
-Change in receivables	78.48%-133K	241.43%857K	16,700.00%166K	-273.88%-426K	-110.90%-58K	-25.35%-618K	--251K	---1K	690.32%245K	8,766.67%532K
-Change in inventory	--0	-200.00%-16K	-78.91%27K	572.37%359K	105.09%102K	34.52%113K	--16K	--128K	72.26%-76K	-1,406.77%-2M
-Change in prepaid assets	-293.00%-882K	115.84%61K	-156.67%-154K	-30.52%-325K	-400.89%-337K	3,908.33%457K	---385K	---60K	-344.64%-249K	11,100.00%112K
-Change in payables and accrued expense	3,601.41%17.37M	-57.74%601K	-419.25%-2.64M	572.00%2.69M	642.16%2.27M	-563.55%-496K	--1.42M	---509K	72.41%400K	355.00%306K
-Change in other working capital	--0	--0	--28M	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	133.29%3.37M	-10.28%-8.9M	242.43%13.85M	-506.52%-36.91M	-211.59%-9.01M	-610.97%-10.11M	---8.07M	---9.72M	-114.52%-6.09M	-158.59%-2.89M
Investing cash flow
Cash flow from continuing investing activities	-13,000.00%-29.74M	-475.04%-3.3M	-287.23%-47.3M	184.51%24.37M	27.64%-89K	-773.08%-227K	-573K	25.26M	-6,933.90%-28.84M	10.87%-123K
Net PPE purchase and sale	-12,989.43%-29.71M	-82.88%-1.02M	-4,413.43%-9.07M	-609.93%-1.07M	15.24%-89K	-773.08%-227K	---555K	---201K	60.26%-151K	8.70%-105K
Net business purchase and sale	--0	--0	--0	--2.7M	--0	--0	--0	--2.7M	----	----
Net investment purchase and sale	--0	---2.28M	-267.92%-38.23M	200.33%22.76M	--0	--0	--0	--22.76M	---22.69M	----
Net other investing changes	----	----	----	99.70%-18K	--0	--0	----	----	-19,900.00%-6M	----
Cash from discontinued investing activities
Investing cash flow	-13,000.00%-29.74M	-475.04%-3.3M	-287.23%-47.3M	184.51%24.37M	27.64%-89K	-773.08%-227K	---573K	--25.26M	-6,933.90%-28.84M	10.87%-123K
Financing cash flow
Cash flow from continuing financing activities	62,700.00%628K	23,744.53%122.08M	208,010.00%166.33M	2,703.57%785K	352K	1K	512K	-80K	-99.96%28K	0
Net issuance payments of debt	23.81%-16K	60.00%-8K	20.00%-12K	---68K	---12K	---21K	---20K	---15K	----	----
Net common stock issuance	---123K	--235.04M	--53.14M	--364K	--364K	--0	--0	--0	--0	--0
Cash dividends paid	----	----	----	----	----	----	----	----	--0	--0
Proceeds from stock option exercised by employees	3,386.36%767K	-1,994.74%-10.08M	--10.33M	1,878.57%554K	--0	--22K	--532K	--0	-94.76%28K	--0
Net other financing activities	----	----	158,353.85%102.87M	---65K	--0	--0	--0	---65K	----	----
Cash from discontinued financing activities
Financing cash flow	62,700.00%628K	23,744.53%122.08M	208,010.00%166.33M	2,703.57%785K	--352K	--1K	--512K	---80K	-99.96%28K	--0
Net cash flow
Beginning cash position	784.83%252.19M	288.43%142.3M	-55.51%9.42M	-62.24%21.18M	-69.26%18.17M	-52.92%28.5M	--36.63M	--21.18M	2,079.25%56.07M	-9.13%59.09M
Current changes in cash	-149.06%-25.74M	1,451.13%109.89M	759.56%132.88M	66.32%-11.76M	-190.15%-8.75M	-613.81%-10.34M	---8.13M	--15.46M	-156.80%-34.9M	-197.53%-3.01M
End cash Position	1,146.59%226.44M	784.83%252.19M	288.43%142.3M	-55.51%9.42M	-83.20%9.42M	-69.26%18.17M	--28.5M	--36.63M	-66.92%21.18M	-12.40%56.07M
Free cash flow	-154.88%-26.35M	-14.95%-9.92M	148.13%4.78M	-509.03%-37.99M	-203.64%-9.1M	-613.88%-10.34M	---8.63M	---9.92M	-93.82%-6.24M	-142.98%-3M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data